SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-17-000189
Filing Date
2017-05-05
Accepted
2017-05-05 17:05:13
Documents
60
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q rgbp033117form10q.htm 10-Q 528293
2 EXHIBIT 10.2 ex10_2.htm EX-10.2 68156
3 EXHIBIT 10.3 ex10_3.htm EX-10.3 66997
4 EXHIBIT 10.4 ex10_4.htm EX-10.4 64979
5 EXHIBIT 10.5 ex10_5.htm EX-10.5 53605
6 EXHIBIT 10.6 ex10_6.htm EX-10.6 49198
7 EXHIBIT 10.11 ex10_11.htm EX-10.11 39043
8 EXHIBIT 31.1 ex31_1.htm EX-31.1 8190
9 EXHIBIT 31.2 ex31_2.htm EX-31.2 8146
10 EXHIBIT 32.1 ex32_1.htm EX-32.1 4945
11 EXHIBIT 32.2 ex32_2.htm EX-32.2 4851
  Complete submission text file 0001607062-17-000189.txt   2903887

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE FILE rgbp-20170331.xml EX-101.INS 357627
13 XBRL SCHEMA FILE rgbp-20170331.xsd EX-101.SCH 32193
14 XBRL CALCULATION FILE rgbp-20170331_cal.xml EX-101.CAL 33930
15 XBRL DEFINITION FILE rgbp-20170331_def.xml EX-101.DEF 138959
16 XBRL LABEL FILE rgbp-20170331_lab.xml EX-101.LAB 169696
17 XBRL PRESENTATION FILE rgbp-20170331_pre.xml EX-101.PRE 167917
Mailing Address 4700 SPRING ST #304 LA MESA CA 91942
Business Address 4700 SPRING ST #304 LA MESA CA 91942 619-702-1404
Regen BioPharma Inc (Filer) CIK: 0001589150 (see all company filings)

IRS No.: 455192997 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 333-191725 | Film No.: 17819341
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences